A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Upadacitinib in Pediatric Subjects With Polyarticular Course Juvenile Idiopathic Arthritis
Clinical trial NCT03725007 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03725007
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-24
- Primary completion
- 2028-12-01
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.